Search hospitals > Ohio > Cleveland
Cleveland Clinic Cancer Center/Fairview Hospital
Claim this profileCleveland, Ohio 44111
Global Leader in Cancer
Global Leader in Ovarian Cancer
Conducts research for Recurrence
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
283 reported clinical trials
34 medical researchers
Summary
Cleveland Clinic Cancer Center/Fairview Hospital is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Ovarian Cancer, Recurrence, Lung Cancer, Adenocarcinoma and other specialties. Cleveland Clinic Cancer Center/Fairview Hospital is involved with conducting 283 clinical trials across 264 conditions. There are 34 research doctors associated with this hospital, such as Peter Rose, MD, David Peereboom, MD, Nathan A. Pennell, and Dale Shepard.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Ovarian Cancer
Global LeaderStage IV
BRCA1 positive
Stage III
Top PIs
Peter Rose, MDCleveland Clinic Foundation1 year of reported clinical research
Expert in Ovarian Cancer
Expert in Ovarian Tumors
25 reported clinical trials
50 drugs studied
David Peereboom, MDCleveland Clinic4 years of reported clinical research
Expert in Glioblastoma
Studies Brain Tumor
18 reported clinical trials
30 drugs studied
Nathan A. PennellCleveland Clinic Foundation2 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
16 reported clinical trials
25 drugs studied
Dale ShepardCleveland Clinic Foundation7 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
38 drugs studied
Clinical Trials running at Cleveland Clinic Cancer Center/Fairview Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Colorectal Cancer
Squamous Cell Carcinoma
Ovarian Cancer
Oropharyngeal Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cleveland Clinic Cancer Center/Fairview Hospital?
Cleveland Clinic Cancer Center/Fairview Hospital is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Ovarian Cancer, Recurrence, Lung Cancer, Adenocarcinoma and other specialties. Cleveland Clinic Cancer Center/Fairview Hospital is involved with conducting 283 clinical trials across 264 conditions. There are 34 research doctors associated with this hospital, such as Peter Rose, MD, David Peereboom, MD, Nathan A. Pennell, and Dale Shepard.